Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Estimated Market Size of the Growth Hormone Deficiency Market In 2029?
The market size for growth hormone deficiency has seen a robust expansion in the past few years. The market, which stood at $4.06 billion in 2024, is projected to rise to $4.31 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The surge observed in the historical period can be credited to several factors, including an increase in strategic initiatives, a rise in reported brain tumor cases, growing demand for hormone therapies, a swelling aged population, and escalated government healthcare funding.
In the coming years, the market size for growth hormone deficiency is projected to experience robust expansion. With a compound annual growth rate (CAGR) of 5.9%, it is anticipated to reach $5.42 billion by 2029. The substantial growth during the predicted period is primarily due to the escalating occurrence of genetic ailments, the increasing count of strategic measures taken, augmented research and development efforts, the escalating morbidity of Gh disease, and a rise in clinical trials. The forecast period will also see key trends like progress in technology, widening range of treatments, improvements in diagnostic procedures, fresh advancements, and progress in biotechnological applications.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21197&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Growth Hormone Deficiency Market?
The upsurge in the incidence of genetic disorders is predicted to accelerate the expansion of the growth hormone deficiency market in the future. Genetic disorders are health problems resulting from irregularities or changes in a person’s DNA, which can be inherited or develop spontaneously. Progress in diagnostic technology, heightened awareness, increasing maternal age, environmental factors leading to mutations, population expansion, and better survival rates for those affected contribute to the increasing prevalence of genetic disorders. Growth hormone deficiency is employed to control growth-related issues in certain genetic disorders. For instance, as stated by the Department of Health & Social Care (DHSC), a government department based in the UK, about 33,000 whole genome equivalents were sequenced in October 2022, boasting an average diagnostic yield of 32%, which increased to 61% in certain conditions as mentioned in their December 2022 report. Hence, the escalating incidence of genetic disorders propels the expansion of the growth hormone deficiency market.
Which Key Market Segments Comprise the Growth Hormone Deficiency Market and Drive Its Revenue Growth?
The growth hormone deficiency market covered in this report is segmented –
1) By Type: Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency
2) By Treatment: Pharmacological Therapy, Recombinant Human Growth Hormone, Human Pituitary Gland Extracts, Surgery
3) By Route Of Administration: Intravenous, Intramuscular, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Pediatric Growth Hormone Deficiency: Idiopathic Growth Hormone Deficiency, Genetic Growth Hormone Deficiency, Acquired Growth Hormone Deficiency
2) By Adult Growth Hormone Deficiency: Primary Growth Hormone Deficiency, Secondary Growth Hormone Deficiency
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21197&type=smp
Which Areas Are Leading Regions in the Growth Hormone Deficiency Market Expansion Across the Globe?
North America was the largest region in the growth hormone deficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the growth hormone deficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theGrowth Hormone Deficiency Market Over the Coming Years?
Leading corporations in the growth hormone deficiency sector are emphasizing the creation of unique products like unmodified somatropin, intended for daily administration in pediatric growth hormone deficiency (GHD) procedures. Unmodified somatropin is the same growth hormone applied in daily pediatric GHD treatments, but it is presented in a once-a-week dosage through Skytrofa. For example, in September 2023, Ascendis Pharma A/S, a biopharmaceutical firm based in Denmark, unveiled SKYTROFA (lonapegsomatropin) for the once-a-week management of pediatric growth hormone deficiency (GHD). This ground-breaking therapy presents improved convenience, enhanced compliance, and possibly superior treatment results compared to conventional daily growth hormone treatments. It is the first and only FDA-endorsed once-a-week treatment for pediatric GHD, setting it as a revolutionary breakthrough in the fields of endocrinology and child healthcare.
View the full report here:
https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report
How Is the Growth Hormone Deficiency Market Conceptually Defined?
Growth hormone deficiency (GHD) is a medical condition in which the pituitary gland does not produce enough growth hormone (GH). This deficiency leads to stunted growth and development in children and various metabolic issues in adults. Growth hormone deficiency can be congenital (present at birth) or acquired due to injury, tumors, infections, or other medical conditions affecting the pituitary gland.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21197
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
